VIVODYNE
Vivodyne develops an automated robotic system that discovers life-changing drugs and cellular therapies. Its platform cultures the most realistic human tissues ever lab-grown to answer deep questions about human health.
VIVODYNE
Social Links:
Industry:
Biotechnology Lifestyle Medical
Founded:
2020-01-01
Address:
Philadelphia, Pennsylvania, United States
Country:
United States
Website Url:
http://www.vivodyne.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
40 M USD
Technology used in webpage:
Domain Not Resolving Cloudflare Hosting Facebook Sharer U.S. Server Location HSTS IncludeSubdomains PreLoad Amazon SSL Next.js Apollo GraphQL Auth0 Chakra UI
Similar Organizations
Aspect Biosystems
Biotech company developing bioprinted tissue therapeutics to transform how we treat disease.
Clarapath
We are a medical robotics company developing the SectionStar, a platform to mimic the human histotechnician.
Modicus Prime
Bringing Self-Service AI to the Life Sciences
Proscia
Proscia develops a pathology platform to assist routine pathology operations, enhance cancer diagnosis, and improve patient outcomes.
ReviR Therapeutics
ReviR Therapeutics is a genomics-based platform that develops novel medicines targeting human RNAs.
Serve Robotics
Serve Robotics develops self-driving robots to deliver food and supplies.
Virgin Pulse
Virgin Pulse is a software company that offers services in employee engagement, productivity, employee health, and workplace wellness.
Current Employees Featured
Founder
Investors List
Kairos Ventures
Kairos Ventures investment in Seed Round - Vivodyne
Khosla Ventures
Khosla Ventures investment in Seed Round - Vivodyne
CS Venture Opportunities Fund
CS Venture Opportunities Fund investment in Seed Round - Vivodyne
MBX Capital
MBX Capital investment in Seed Round - Vivodyne
Bison Ventures
Bison Ventures investment in Seed Round - Vivodyne
Kairos Ventures
Kairos Ventures investment in Seed Round - Vivodyne
Key Employee Changes
| Date | New article |
|---|---|
| 2024-01-31 | Vivodyne Appoints Elliot Menschik, M.D., Ph.D., as Chief Technology Officer |
Official Site Inspections
http://www.vivodyne.com Semrush global rank: 5.46 M Semrush visits lastest month: 1.35 K
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 75.2.70.75
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Vivodyne"
Vivodyne - Human Data Before The Clinic
We create human data to develop better therapeutics. Our platform enables human testing before clinical trials. Our portfolio of lifelike human organs yields realistic, reproducible, and clinically …See details»
About Us - Vivodyne
At Vivodyne, we are changing how scientists study human biology and develop therapeutics. Our mission is to provide greater certainty of drugs entering clinical trials. Vivodyne Announces $38M in Seed FinancingSee details»
Our Platform - Vivodyne
Our 3D human tissues are designed to reconstitute the cellular, tissue, organ, and systemic organization and function of the native human tissues that they model — containing 200,000 to 500,000 cells each with fully perfusable blood vessel …See details»
Vivodyne - Crunchbase Company Profile & Funding
Vivodyne develops an automated robotic system that discovers life-changing drugs and cellular therapies. Its platform cultures the most realistic human tissues ever lab-grown to answer deep questions about human health.See details»
Vivodyne lands $38m to predict drug effects using lab …
Nov 22, 2023 · US biotech company Vivodyne has secured a whopping $38 million seed financing to advance its AI powered predictive drug development platform, which revolves around testing drugs on lab-grown human organs to …See details»
Vivodyne launches for drugs tested on lab-grown human organs
Dec 3, 2023 · Vivodyne has launched with $38 million in seed funding, led by the investment firm Khosla Ventures, to discover and develop drugs by testing them on lab-grown human organs. …See details»
Vivodyne named #1 “Small but Mighty” Company
Mar 8, 2022 · Launched in 2021, Vivodyne’s lab-grown human organ tissue platform allows fully automated complex studies to be performed at a far larger scale and lower cost than manual experimentation. In addition, the platform …See details»
Vivodyne - VentureRadar
Website: https://vivodyne.com/ Accelerates drug development by testing on lab-grown human organs, using robotic automation and AI to bridge preclinical R&D and clinical trials. …See details»
Vivodyne Company Profile 2024: Valuation, Funding & Investors
Developer of microfluidic bioengineering platform designed to revolutionize single-cell 4D phenomics and discover drugs and cellular therapies.See details»
Careers - Vivodyne
Join a highly driven team of ambitious doers who are improving how cures to human diseases are discovered, developed, and brought to patients in need.See details»
This startup is solving the biggest problems in drug …
Dec 9, 2023 · Biotech startup Vivodyne is planning to revolutionize drug development with an AI-powered robot that can grow, dose, and analyze thousands of samples of human tissues at once.See details»
Vivodyne's Lab Grown Human Tissue Platform Gets Real with $38 …
Nov 22, 2023 · Vivodyne’s AI-driven platform is used to discover and develop drugs by testing directly on lab-grown human organ tissues.See details»
Vivodyne Announces $38 Million Seed Financing Led by Khosla …
Nov 22, 2023 · PHILADELPHIA-- ( BUSINESS WIRE )-- Vivodyne, a biotech that discovers and develops more effective drugs by testing them on lab-grown human organs, today announced …See details»
Vivodyne raised $38 million to fill drug discovery gap - Forbes …
Nov 22, 2023 · That’s where Georgescu’s company, Vivodyne, comes in. It’s building human organ tissues in the lab that can be used for preclinical testing of potential drugs, as well as AI …See details»
Vivodyne launches with $38M to create lab-grown human organs
Nov 22, 2023 · Vivodyne is a drug discovery company that uses clinically predictive AI to help identify therapeutic targets and predict a patient's response to a drug by testing it on lab-grown …See details»
Vivodyne - Human Organ Models
We cultivate human tissues in 3D microfluidics to recreate the complex functions and behaviors of native human organs — all at incredible throughput. With each human tissue containing …See details»
Vivodyne is the Latest Startup from UPenn ... - Kairos Ventures
Mar 30, 2021 · Vivodyne is changing how scientists study human biology & develop therapeutics. Their platform technology creates a new preclinical drug development pipeline – Pipeline V – …See details»
Vivodyne Announces $38 Million Seed Financing Led by Khosla …
PHILADELPHIA, November 22, 2023 -- (BUSINESS WIRE)-- Vivodyne, a biotech that discovers and develops more effective drugs by testing them on lab-grown human organs, today …See details»
Vivodyne - Partner With Us
Our platform accelerates the development of new therapies with preclinical human data. Ultra-realistic, lab-grown human organ tissue models. Human data-powered AI that optimizes new …See details»
Vivodyne: $38 Million Closed To Develop More Effective Drugs By …
Dec 6, 2023 · Vivodyne - a biotech that discovers and develops more effective drugs by testing them on lab-grown human organs - recently announced the closing of $38 million in total seed …See details»